12:00 AM
 | 
Nov 11, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Amgen Inc.

(AMGN), Thousand Oaks, Calif.

Business: Biopharmaceuticals

UBS Warburg analyst Meirav Chovav lowered her rating to "hold" from "buy" based...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >